Meet the board

 Professor Mike Smith - BSc, MSc, PhD, DSc, CPhys, CSci, FInstKT, FBIR, FIPSM, FInstP - Non-Executive Director and Chair

Mike has 45 years’ experience as an academic and medical scientist working in the University/NHS /Commercial sectors in Edinburgh, London, Leeds, Teesside and Sheffield with a wide network of international links. He has international research experience with associated record of peer-reviewed publications (more than 200) and grant income (~£55m). He has extensive experience with EU programmes in the various Frameworks, supporting innovation development, adoption and links between innovators and the commercial sector He has published patents, licensed research developments, formed spin-off companies and held non-executive appointments commercial sector and the NHS, and Trustee roles in the Charitable sector. For over 25 years’ Mike has served on major professional and government national committees including: RAE Panel Member on two occasions; NHS Central R&D Committee; MRC Medical Advisory Board; NHS New and Emerging Applications of Technology (NEAT) and i4i Advisory Board; NHS R&D Standing Group on Health Technology Assessment; and DTI Foresight Taskforce on Biotechnology, Pharmaceuticals and Medical Devices.  He has contributed at a national level on policy and funding issues, working at a high level with all relevant government departments, the EU and a number of RDAs. He gained leadership experience in a number of organisations (public sector), which included operational and strategic management responsibility for large budgets (>£300m). This involved (i) major capital building projects and (ii) the formation and closure of units and (iii) major strategic restructuring. His involvement with regional programmes in the North East of England and in Yorkshire, included (i) lead for DigitalCity in Middlesborough, a large scale regional development programme supporting innovation and SMEs, (ii) Member of the Board of Advanced Manufacturing Park, (iii) Steering Group for the Digital Campus, (iv) Steering Group of the Sheffield Economic Masterplan, (v) Member of the Board of Knowledge Starts, (vi) the development of the Local Enterprise Partnership and (vii) the Region Growth Hub. Mike also acted as external advisor for Daresbury Research in the north west of England, taking a bid for a national research facility through the government’s comprehensive spending review (2002)

 Mr DJ Dickson, FCA – Non-Executive Director, Chair of the Finance & Resources Sub-Committee

David is the Chairman of the Family Business Committee of Shepherd Group, one of the largest family businesses in the UK. He has have been The Treasurer and Chair of the finance committee of the University of York for 11 years, where they have a turnover of£370m and have spent in excess of £500m on campus development and almost doubled student numbers in that period. The University deals with a multitude of national and international grants and have a research income of £72m. As Deputy Chair of the York North Yorkshire East Ridding LEP David been involved in successful applications to Government for significant funding (plus £200m) and meets with regional and national politicians to discuss the appropriate use of Funds to support the SME community. He Chairs the Regional Infrastructure Board, responsible for the allocation of£150m of the central government Local Growth Fund and then subsequently monitoring performance. He is a member of the Enterprise Zone Board for the delivery of York Central which will ultimately be a £2b development where at present they monitor the infrastructure plan and the raising of £155m, working with a series of Stakeholders. He is member of the Northern power house Investment Fund, Regional Advisory Board which monitors a£400m fund to support SME companies in the North of England. He is Chair of St Leonards Hospice which manages NHS funding to provide with other stakeholders Palliative care in the Region. As a Business Angel with investments in knowledge-based and early stage businesses, he also provides strategic guidance, business and mentoring support. For 26 years until 2015 David was the Senior Partner of Garbutt and Elliott, a regional firm of Chartered Accountants joining them from KPMG in 1989

 Janette Bennadi – Non-executive Director

Janette is a business woman, international speaker and consultant to the life science industries. Despite poor performance at school Janette eventually qualified as a nurse, a teacher and a counsellor. She is a very successful business woman and ran a medical device company she setup and owned for over 20 years until its sale in 2013. She is very well known in the medical device industry and has been instrumental in helping to bring new medical technology to market.

Janette would not describe herself as an adventurer and would never have dreamed that one day she would row across an ocean in a small rowing boat. However, in 2015 Janette along with 3 other women became the first women to row across the North Sea. A year later Janette was Skipper of the Yorkshire Rows Team and with the same 3 women successfully rowed 3000 Nautical miles across the Atlantic Ocean to gain a Guinness world record.

The taste of an adventure has inspired her to go on and complete the London marathon running as a guide for a friend who is completely blind. Janette is co-author of the book “Four mums in a boat” and is currently writing a book about her business adventures.  She is passionate about helping SMEs to flourish and grow as well as enjoying her work as a Non-Executive Director.

 Professor J Hutton, BSc, BPhil – Non-executive Director

John has over 35 years’ experience of research, teaching and consulting in health economics and health technology assessment. His early academic career was in Aberdeen, then York where he organised the UK Health Economists’ Study Group, and was a founder member of ISTAHC (now HTAi) and a founding co-editor of the journal Health Economics. At MEDTAP International John was head of its European operations, working on health technology evaluation projects for major pharmaceutical and medical device companies, HTA agencies and other health service organisations. He played a leading role in helping the new UK National Institute for Clinical Excellence (NICE) develop its first evaluation guidance for manufacturers (he is still an adviser to the NICE Clinical Guidelines Programme), and advised similar agencies in other European countries. He returned to the University of York as Professor of Health Economics in the Department of Health Sciences and Director of the York Health Economics Consortium (YHEC), Under his leadership YHEC became a support centre for the NICE Medical Technologies Programme. In addition to publishing widely on the development and application of economic evaluation methods in health care, he has been directly involved in health care decision-making. From 2005 to 2014 he was a Non-executive Director; first at York Teaching Hospitals Trust and latterly at the University Hospitals of Morecambe Bay, where he was acting Chairman. From 2008 to March 2015 he was a member of the NICE Technology Appraisal Committee, and contributed to the NICE Public Health and Primary Care programmes. He led the UK part of EU Interquality project, which looked at financial incentives and quality of health care, on behalf of the Health Sciences Department at the University of York and was a member of the project management committee.

 

  Ann Starkey MBA, FInstKT – Non-executive Director and Company Secretary

Ann has over 40 years’ experience of working at the interface between Higher Education and the Medical and Healthcare Sector. Originally she worked in research and project management in the Faculty of Medicine and Health at the University of Leeds University, where she managed the School’s R&D budget of £18m pa and oversaw the transfer of the Clinical Trials and Research Unit from the Regional Health Authority to the University of Leeds. This was followed by innovation and business development, at Medipex Ltd, an company set up to commercialise innovations emerging from the Health sector in the Yorkshire and Humber Region of the UK; prior to joining Medipex she was part of the Executive Team that set up the Company.Ann’s project management and business development expertise has involved her with a number of strategic initiatives including: the Sheffield City Region Local Enterprise Partnership Health Technology Sector Group; the Board of the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) in West Yorkshire; the National Innovation Centre Metrics Working Group; the Steering Committee Devices for Dignity (D4D) Healthcare Technology Co-operative (HTC) Programme. At Medipex she was involved in raising over £1m in PSRE funding. Ann was the first Chair of the Healthcare Strategy Board of the Transatlantic Business Council, from 2010-13. She has given presentations on IP management at National and International meetings. She is a Senior Member of the ESRC Peer Review College. She mentors staff who are recently appointed to Senior Management Roles.

 Professor PW Dettmar – Non-Executive Director and Chair of the Project Appraisal Sub-Committee

Peter is the former global R&D Director Gastrointestinals Reckitt Benckiser Healthcare (UK) Limited with extensive experience in running product development programs and clinical trials and over 35 years experience of the pharmaceutical industry. He is the named inventor on over 40 patents,has supervised more that 70 successful PhD studentships and authored or co-authored over 480 scientific/clinical publications. He established and is the Managing Director of Technostics Limited and RD Biomed Limited two innovative pharmaceutical development and diagnostic companies based in Hull, East Yorkshire. Peter has also been involved in the EU Framework programmes running collaborative research projects; the BBSRC Consortium Programmes with responsibility for research projects within the programmes, and the Director of TSB Smart Award and co-ordinated research programme. He is a Member of leadership team for National Institute for Health Research Funding with the NHS (NIHR) – i4i Product Development Award.

 Richard Clark, BSc, MSc – Non-executive Director

Dick is a business development strategist whose career spans over 35 years as a chartered engineer involving design and project management in diverse sectors such as energy, environmental industry and most recently in medical engineering. During this time he has acquired a broad base both of practical and technical skills together with a track record in technology transfer and commercial exploitation. He has published over 15 technical papers, acted as an international environmental consultant, been co-chair and presented papers at numerous international conferences and has several patents to his name. He was responsible for the establish and operation of the first Medilink and over the last 25 years has worked with many innovative medical technology SMEs helping them develop new products and processes arising from the research base, providing commercial advice, helping to secure funding, and to understand the needs/opportunities of working with NHS and helping them to export. Dick has direct experience of securing and managing EU innovation funds (ERDF, STRIDE, etc), UK innovation funds (SMART, Innovate UK, i4i and regional innovation grants). As CEO of Medipex he managed 3 rounds of PSRE to build capacity and innovation infrastructure within NHS, and was responsible for establishing 9 medical technology spin outs and securing funding for them plus acting as interim management.